Form 4: Solventum CHRO Gomez Reports Stock Transactions

Solventum's Chief Human Resources Officer, Tammy L. Gomez, reported the acquisition of common stock through RSU vesting and subsequent sale for tax purposes.

Summary

• Tammy L. Gomez, Chief Human Resources Officer of Solventum Corp (SOLV), reported transactions involving the company's common stock and Restricted Stock Units (RSUs).
• On January 2, 2026, 4,342 Restricted Stock Units vested and were converted into an equal number of common shares.
• Concurrently, 1,332 shares of common stock were disposed of at a price of $79.2 per share to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Gomez beneficially owns 8,665 shares of Solventum Corp common stock.
• Gomez continues to hold 4,342 unvested Restricted Stock Units, which represent a contingent right to receive one share of common stock per unit upon settlement.
• These remaining RSUs are scheduled to vest in three equal tranches on the first, second, and third anniversaries of their grant date, subject to continued service.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing reports a routine RSU vesting and associated tax sale, which is a normal part of executive compensation. The executive's beneficial ownership increased net of taxes, indicating continued alignment with shareholder interests.

Positives

• The vesting of Restricted Stock Units indicates continued employment and aligns executive interests with shareholder value.
• The acquisition of 4,342 common shares increases the executive's direct ownership in the company, net of tax-related sales.

Negatives

• The disposition of 1,332 shares, while for tax purposes, reduces the immediate net increase in direct share ownership from the RSU vesting.

Future Outlook

The filing indicates future vesting of remaining Restricted Stock Units in three tranches on the first, second, and third anniversaries of the grant date, subject to continued service.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions, common across all publicly traded companies. It reflects standard executive compensation practices involving equity awards and their vesting schedules.

Comparison to Industry Standards

• The RSU vesting and subsequent tax-related sale are standard practices for executive compensation in the U.S. market.
• The structure of RSUs vesting over multiple years is a common mechanism to align executive incentives with long-term company performance and retention, consistent with practices at peer companies in the industrial or healthcare sectors (e.g., 3M, Danaher, Medtronic).

Stakeholder Impact

• Shareholders: Increased alignment of executive's interests with shareholders due to increased direct stock ownership.
• Employees: Standard executive compensation practices are being followed.

Next Steps

• Future vesting of remaining Restricted Stock Units on the first, second, and third anniversaries of the grant date.

Key Dates

Recommendation

This Form 4 filing details a routine executive stock transaction involving RSU vesting and a tax-related sale. It does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction reflects standard executive compensation practices and a slight increase in the executive's beneficial ownership, which is generally neutral to slightly positive for alignment but not a catalyst for a 'buy' or 'sell' decision.

Keywords

Solventum Corp, SOLV, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Ownership, Tammy L. Gomez, Chief Human Resources Officer